Cargando…
Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial
BACKGROUND: Relapses of childhood steroid-sensitive nephrotic syndrome (SSNS) are treated with a 4- to 8-week course of high-dose oral prednisolone, which may be associated with significant adverse effects. There is a clear association between upper respiratory tract infection (URTI) and relapse dev...
Autores principales: | Webb, Nicholas J A, Frew, Emma, Brettell, Elizabeth A, Milford, David V, Bockenhauer, Detlef, Saleem, Moin A, Christian, Martin, Hall, Angela S, Koziell, Ania, Maxwell, Heather, Hegde, Shivram, Finlay, Eric R, Gilbert, Rodney D, Booth, Jenny, Jones, Caroline, McKeever, Karl, Cook, Wendy, Ives, Natalie J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030532/ https://www.ncbi.nlm.nih.gov/pubmed/24767719 http://dx.doi.org/10.1186/1745-6215-15-147 |
Ejemplares similares
-
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial
por: Christian, Martin T., et al.
Publicado: (2021) -
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
por: Afentou, Nafsika, et al.
Publicado: (2022) -
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation
por: Webb, Nicholas J A, et al.
Publicado: (2019) -
Shared genetic risk across different presentations of gene test–negative idiopathic nephrotic syndrome
por: Downie, Mallory L., et al.
Publicado: (2022) -
Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome
por: Schijvens, Anne M., et al.
Publicado: (2018)